Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 97

1.

Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.

Brain K, Carter B, Lifford KJ, Burke O, Devaraj A, Baldwin DR, Duffy S, Field JK.

Thorax. 2017 Jul 14. pii: thoraxjnl-2016-209690. doi: 10.1136/thoraxjnl-2016-209690. [Epub ahead of print]

2.

The impact of trained radiographers as concurrent readers on performance and reading time of experienced radiologists in the UK Lung Cancer Screening (UKLS) trial.

Nair A, Screaton NJ, Holemans JA, Jones D, Clements L, Barton B, Gartland N, Duffy SW, Baldwin DR, Field JK, Hansell DM, Devaraj A.

Eur Radiol. 2017 Jun 22. doi: 10.1007/s00330-017-4903-z. [Epub ahead of print]

PMID:
28643093
3.

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.

Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R, Le Quesne J, Moore DA, Veeriah S, Rosenthal R, Marafioti T, Kirkizlar E, Watkins TBK, McGranahan N, Ward S, Martinson L, Riley J, Fraioli F, Al Bakir M, Grönroos E, Zambrana F, Endozo R, Bi WL, Fennessy FM, Sponer N, Johnson D, Laycock J, Shafi S, Czyzewska-Khan J, Rowan A, Chambers T, Matthews N, Turajlic S, Hiley C, Lee SM, Forster MD, Ahmad T, Falzon M, Borg E, Lawrence D, Hayward M, Kolvekar S, Panagiotopoulos N, Janes SM, Thakrar R, Ahmed A, Blackhall F, Summers Y, Hafez D, Naik A, Ganguly A, Kareht S, Shah R, Joseph L, Marie Quinn A, Crosbie PA, Naidu B, Middleton G, Langman G, Trotter S, Nicolson M, Remmen H, Kerr K, Chetty M, Gomersall L, Fennell DA, Nakas A, Rathinam S, Anand G, Khan S, Russell P, Ezhil V, Ismail B, Irvin-Sellers M, Prakash V, Lester JF, Kornaszewska M, Attanoos R, Adams H, Davies H, Oukrif D, Akarca AU, Hartley JA, Lowe HL, Lock S, Iles N, Bell H, Ngai Y, Elgar G, Szallasi Z, Schwarz RF, Herrero J, Stewart A, Quezada SA, Peggs KS, Van Loo P, Dive C, Lin CJ, Rabinowitz M, Aerts HJWL, Hackshaw A, Shaw JA, Zimmermann BG; TRACERx consortium; PEACE consortium, Swanton C.

Nature. 2017 Apr 26;545(7655):446-451. doi: 10.1038/nature22364.

PMID:
28445469
4.

Tracking the Evolution of Non-Small-Cell Lung Cancer.

Jamal-Hanjani M, Wilson GA, McGranahan N, Birkbak NJ, Watkins TBK, Veeriah S, Shafi S, Johnson DH, Mitter R, Rosenthal R, Salm M, Horswell S, Escudero M, Matthews N, Rowan A, Chambers T, Moore DA, Turajlic S, Xu H, Lee SM, Forster MD, Ahmad T, Hiley CT, Abbosh C, Falzon M, Borg E, Marafioti T, Lawrence D, Hayward M, Kolvekar S, Panagiotopoulos N, Janes SM, Thakrar R, Ahmed A, Blackhall F, Summers Y, Shah R, Joseph L, Quinn AM, Crosbie PA, Naidu B, Middleton G, Langman G, Trotter S, Nicolson M, Remmen H, Kerr K, Chetty M, Gomersall L, Fennell DA, Nakas A, Rathinam S, Anand G, Khan S, Russell P, Ezhil V, Ismail B, Irvin-Sellers M, Prakash V, Lester JF, Kornaszewska M, Attanoos R, Adams H, Davies H, Dentro S, Taniere P, O'Sullivan B, Lowe HL, Hartley JA, Iles N, Bell H, Ngai Y, Shaw JA, Herrero J, Szallasi Z, Schwarz RF, Stewart A, Quezada SA, Le Quesne J, Van Loo P, Dive C, Hackshaw A, Swanton C; TRACERx Consortium.

N Engl J Med. 2017 Jun 1;376(22):2109-2121. doi: 10.1056/NEJMoa1616288. Epub 2017 Apr 26.

PMID:
28445112
5.

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.

Arce Vargas F, Furness AJS, Solomon I, Joshi K, Mekkaoui L, Lesko MH, Miranda Rota E, Dahan R, Georgiou A, Sledzinska A, Ben Aissa A, Franz D, Werner Sunderland M, Wong YNS, Henry JY, O'Brien T, Nicol D, Challacombe B, Beers SA; Melanoma TRACERx Consortium; Renal TRACERx Consortium; Lung TRACERx Consortium, Turajlic S, Gore M, Larkin J, Swanton C, Chester KA, Pule M, Ravetch JV, Marafioti T, Peggs KS, Quezada SA.

Immunity. 2017 Apr 18;46(4):577-586. doi: 10.1016/j.immuni.2017.03.013. Epub 2017 Apr 11.

6.

A lesson in plasticity: a 74-year-old man with plastic bronchitis.

Shah A, Donovan J, Marino P, Shah PL, Devaraj A, Wechalekar K, Maher TM, Loebinger MR, Wilson R.

Thorax. 2017 Apr 3. pii: thoraxjnl-2017-209965. doi: 10.1136/thoraxjnl-2017-209965. [Epub ahead of print] No abstract available.

PMID:
28373346
7.

Radiomics of pulmonary nodules and lung cancer.

Wilson R, Devaraj A.

Transl Lung Cancer Res. 2017 Feb;6(1):86-91. doi: 10.21037/tlcr.2017.01.04. Review.

8.

Special issue on thoracic imaging.

Devaraj A.

Clin Radiol. 2017 May;72(5):341-342. doi: 10.1016/j.crad.2017.02.006. Epub 2017 Mar 9. No abstract available.

PMID:
28285705
9.

Optimum low dose CT screening interval for lung cancer: the answer from NELSON?

Baldwin DR, Duffy SW, Devaraj A, Field JK.

Thorax. 2017 Jan;72(1):6-7. doi: 10.1136/thoraxjnl-2016-209011. Epub 2016 Oct 21. No abstract available.

PMID:
27974632
10.

Discerning the Location and Nature of Coke Deposition from Surface to Bulk of Spent Zeolite Catalysts.

Devaraj A, Vijayakumar M, Bao J, Guo MF, Derewinski MA, Xu Z, Gray MJ, Prodinger S, Ramasamy KK.

Sci Rep. 2016 Nov 23;6:37586. doi: 10.1038/srep37586.

11.

The natural armors of fish: A comparison of the lamination pattern and structure of scales.

Murcia S, Lavoie E, Linley T, Devaraj A, Ossa EA, Arola D.

J Mech Behav Biomed Mater. 2017 Sep;73:17-27. doi: 10.1016/j.jmbbm.2016.09.025. Epub 2016 Sep 20.

PMID:
27745845
12.

An emerging interstitial lung disease.

George PM, Devaraj A, Nicholson AG, Chua F.

Lancet Respir Med. 2016 Sep;4(9):762. doi: 10.1016/S2213-2600(16)30242-9. No abstract available.

PMID:
27599249
13.

Implementation planning for lung cancer screening: five major challenges.

Field JK, Duffy SW, Devaraj A, Baldwin DR.

Lancet Respir Med. 2016 Sep;4(9):685-7. doi: 10.1016/S2213-2600(16)30233-8. No abstract available.

PMID:
27599242
14.

Role of 4-tert-Butylpyridine as a Hole Transport Layer Morphological Controller in Perovskite Solar Cells.

Wang S, Sina M, Parikh P, Uekert T, Shahbazian B, Devaraj A, Meng YS.

Nano Lett. 2016 Sep 14;16(9):5594-600. doi: 10.1021/acs.nanolett.6b02158. Epub 2016 Aug 26.

PMID:
27547991
15.

Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial.

Brain K, Lifford KJ, Carter B, Burke O, McRonald F, Devaraj A, Hansell DM, Baldwin D, Duffy SW, Field JK.

Thorax. 2016 Nov;71(11):996-1005. doi: 10.1136/thoraxjnl-2016-208283. Epub 2016 Jul 28.

16.

Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial.

Nair A, Gartland N, Barton B, Jones D, Clements L, Screaton NJ, Holemans JA, Duffy SW, Field JK, Baldwin DR, Hansell DM, Devaraj A.

Br J Radiol. 2016 Oct;89(1066):20160301. doi: 10.1259/bjr.20160301. Epub 2016 Jul 27.

PMID:
27461068
17.

Lung cancer risk in new pulmonary nodules: implications for CT screening and nodule management.

Baldwin DR, Devaraj A.

Lancet Oncol. 2016 Jul;17(7):849-50. doi: 10.1016/S1470-2045(16)30134-6. Epub 2016 Jun 6. No abstract available.

PMID:
27283864
18.

The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.

Field JK, Duffy SW, Baldwin DR, Brain KE, Devaraj A, Eisen T, Green BA, Holemans JA, Kavanagh T, Kerr KM, Ledson M, Lifford KJ, McRonald FE, Nair A, Page RD, Parmar MK, Rintoul RC, Screaton N, Wald NJ, Weller D, Whynes DK, Williamson PR, Yadegarfar G, Hansell DM.

Health Technol Assess. 2016 May;20(40):1-146. doi: 10.3310/hta20400.

19.

Follicular dendritic cell tumour/sarcoma: a commonly misdiagnosed tumour in the thorax.

Viola P, Vroobel KM, Devaraj A, Jordan S, Ladas G, Dusmet M, Montero A, Rice A, Wotherspoon AC, Nicholson AG.

Histopathology. 2016 Nov;69(5):752-761. doi: 10.1111/his.12998. Epub 2016 Jul 8.

PMID:
27206572
20.

Central pulmonary arteries in idiopathic pulmonary fibrosis: size really matters.

Price LC, Devaraj A, Wort SJ.

Eur Respir J. 2016 May;47(5):1318-20. doi: 10.1183/13993003.00272-2016. No abstract available.

PMID:
27132263

Supplemental Content

Loading ...
Support Center